News >

Neoadjuvant Chemo Shows Comparable Data to Upfront Surgery in Ovarian Cancer

Ellie Leick
Published: Thursday, Aug 08, 2019

Michelle M. Boisen, MD

Michelle M. Boisen, MD

Recent trials, such as the SCORPION study, continue to compare the outcomes of patients who undergo upfront surgery versus neoadjuvant chemotherapy in ovarian cancer, and could address unanswered questions in the community, explained Michelle M. Boisen, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 2nd Annual School of Nursing Oncology™Sep 28, 20191.5
Oncology Briefings™: A Nurses' Guide to Managing Adverse Events Associated with PARP InhibitorsJun 30, 20201.0
Publication Bottom Border
Border Publication